Infectious Diseases
Lyme Disease
Diagnose Lyme disease from syndrome-specific pretest probability, use validated two-tier serology when confirmation changes management, recognize carditis and neurologic emergencies, and select short, manifestation-directed antibiotic courses while avoiding unnecessary prolonged therapy.
Initial decision
Triage by manifestation before ordering tests
Identify conduction disease, meningitis, radiculopathy, and inflammatory arthritis before interpreting serology.
Treat a patient with one or more classic erythema migrans lesions in an endemic area clinically, without laboratory confirmation. Serology is often insensitive early in infection, whereas an atypical expanding lesion or extracutaneous syndrome warrants validated two-tier testing because these presentations overlap with other illnesses. Nature+2NatureRapid single-tier serodiagnosis of Lyme disease | Nature CommunicationsPubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedLyme Disease - StatPearls - NCBI Bookshelf
Obtain a 12-lead ECG promptly for palpitations, presyncope or syncope, dyspnea, chest pain, or other concern for Lyme carditis. Lyme carditis affects the cardiac conduction system and can produce arrhythmia, poor cardiac function, hypotension, or syncope; symptomatic patients or those with clinically important conduction disease need hospital-level monitoring rather than outpatient empiric treatment alone. PubMedPubMedLyme disease: diagnosis and management
For acute facial palsy, painful radiculopathy, peripheral neuropathy, or meningitic symptoms after compatible tick exposure, distinguish peripheral neuroborreliosis from alternative infectious and inflammatory neuropathies. Neurologic manifestations have been reported in 3%-12% of Lyme disease cases and may occur with intense pain, facial palsy, radiculopathy, neuropathy, or meningitis. NatureNatureLyme Disease Patient Trajectories Learned from Electronic Medical Data for Stratification of Disease Risk and Therapeutic Response | Scientific Reports
An acute or subacute large-joint inflammatory effusion, particularly a knee-predominant pattern, raises Lyme arthritis but should not defer arthrocentesis when septic arthritis remains plausible. Serology is the preferred diagnostic test for suspected Lyme arthritis; antibody testing of synovial fluid is not recommended. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease
Classic erythema migrans: begin oral treatment; do not delay for testing. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf
Atypical rash or nonspecific febrile illness: assess exposure geography and competing diagnoses, then use two-tier serum serology only when pretest probability is meaningful. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease
Syncope, chest pain, palpitations, dyspnea, or documented heart block: obtain ECG and evaluate for monitored admission. PubMedPubMedLyme disease: diagnosis and management
Acute monoarthritis with systemic toxicity or marked pain with passive motion: aspirate the joint and pursue septic arthritis evaluation before attributing findings to Lyme disease.
| Presentation | Immediate action | Testing and interpretation | Treatment direction |
|---|---|---|---|
| Classic erythema migrans in an endemic area | Treat clinically. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | Do not require serology before treatment. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | Doxycycline for 10 days or amoxicillin or cefuroxime axetil for 14 days. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf |
| Atypical expanding lesion or extracutaneous syndrome | Estimate epidemiologic and syndrome-specific pretest probability. IDSAIDSALyme Disease | Order standard or modified two-tier serum testing. CDC+1CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCIDSALyme Disease | Treat according to the confirmed clinical manifestation. BMJ+1BMJLyme disease - Management Approach | BMJ Best PracticePubMedLyme Disease - StatPearls - NCBI Bookshelf |
| Palpitations, syncope, dyspnea, chest pain, conduction abnormality | Obtain ECG; assess need for hospitalization and monitoring. PubMedPubMedLyme disease: diagnosis and management | Evaluate for Lyme carditis in a compatible exposure setting; exclude other causes of arrhythmia. PubMedPubMedLyme disease: diagnosis and management | Oral doxycycline, amoxicillin, or cefuroxime if not hospitalized; total antibiotic duration 14-21 days. BMJBMJLyme disease - Management Approach | BMJ Best Practice |
| Large-joint inflammatory arthritis | Exclude septic arthritis when clinically indicated. | Use serum serology; avoid synovial-fluid antibody assays. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease | Oral doxycycline for 28 days initially. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf |
Diagnostic testing
Use two-tier serology and interpret it in clinical time
A positive antibody result is meaningful only when the clinical syndrome and exposure risk support Lyme disease.
Use the CDC two-step algorithm for patients whose presentation requires laboratory confirmation. Standard two-tier testing uses a first-tier EIA followed, when the screen is positive or equivocal, by IgM and IgG immunoblotting; modified two-tier testing uses two different EIAs. The overall result is positive only when both tiers meet the assay-specific positivity criteria. If the first-tier test is negative, do not perform additional serologic testing in that specimen. CDC+1CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCIDSALyme Disease
Modified two-tier algorithms offer sensitivity comparable to conventional EIA-immunoblot testing and avoid subjective immunoblot interpretation. Their key limitation in late manifestations is that polyvalent EIAs may not distinguish IgM from IgG or show whether the IgG response is expanded, information that can be useful when evaluating suspected late Lyme arthritis. PubMed+1PubMedLaboratory Diagnosis of Lyme Borreliosis - PMCIDSALyme Disease
Time serology to the biology of the syndrome. Two-tier testing has low sensitivity in early infection, so a negative result does not exclude early erythema migrans; initially seronegative infected patients typically become strongly seropositive when retested several weeks later. Conversely, current assays do not distinguish active from remote infection, and seropositivity may persist for years. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease
Do not diagnose late Lyme disease from isolated IgM reactivity. IgM is relevant primarily during illness of less than 1 month; CDC case-definition criteria direct low-incidence states to disregard IgM results obtained more than 30 days after symptom onset. For conventional immunoblots, IgM positivity requires at least two of three designated bands, while IgG positivity requires at least five of ten designated bands. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDC
Positive or equivocal first-tier EIA: reflex to the designated second-tier immunoblot or a different EIA in a modified two-tier algorithm. CDCCDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC
Negative first-tier EIA: stop serologic testing unless a new specimen is justified by evolving early compatible illness. CDC+1CDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDCIDSALyme Disease
Symptoms exceeding 30 days with IgM-only immunoblot reactivity: seek an alternative diagnosis or objective evidence of recent infection rather than treating the IgM result as late Lyme disease. PubMed+2PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedImmunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive ApproachesCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDC
Avoid nonvalidated specialty assays and nonstandard immunoblot interpretation because they reduce specificity without documented sensitivity advantage. PubMedPubMedLaboratory Diagnosis of Lyme Disease - Advances and Challenges
| Result or setting | Interpretation | Next action |
|---|---|---|
| Classic erythema migrans | Early serology may be negative and is not required for diagnosis. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedLyme Disease - StatPearls - NCBI Bookshelf | Treat clinically. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf |
| Negative first-tier EIA | CDC two-step testing is negative; no second step is recommended. CDCCDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC | Reassess pretest probability and alternate diagnoses; repeat after several weeks only if early compatible illness remains plausible. IDSAIDSALyme Disease |
| Positive/equivocal first-tier EIA with negative second tier | Does not establish seropositivity in the two-tier algorithm. PubMed+1PubMedLaboratory Diagnosis of Lyme Borreliosis - PMCCDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC | Do not diagnose Lyme disease from the screening assay alone; reassess timing and differential. |
| Two-tier positive result | Supports exposure or infection in the appropriate clinical setting but does not prove active infection. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease | Match treatment to an objective compatible manifestation. |
| IgM-only positivity after >30 days | High risk of misleading interpretation; late disease assessment should rely on IgG evidence. PubMed+2PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedImmunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive ApproachesCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDC | Evaluate alternate diagnoses and avoid treating based on isolated late IgM. |
Antimicrobial therapy
Choose treatment by objective manifestation and response
Use short, syndrome-directed courses; escalation depends on objective disease rather than residual nonspecific symptoms.
For erythema migrans without cardiovascular or neurologic involvement, use doxycycline for 10 days or amoxicillin or cefuroxime axetil for 14 days. Azithromycin for 5-10 days is a second-line option when the preferred agents cannot be used. Erythema migrans usually resolves within 1-2 weeks, while systemic symptoms can improve more slowly. PubMed+1PubMedLyme Disease - StatPearls - NCBI BookshelfPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Treat Lyme carditis for 14-21 days. Patients who do not require hospitalization can receive oral doxycycline, amoxicillin, or cefuroxime. Symptoms indicating conduction-system involvement require ECG-based triage and inpatient management when severe conduction disease or hemodynamic consequences are present. BMJ+1BMJLyme disease - Management Approach | BMJ Best PracticePubMedLyme disease: diagnosis and management
Treat Lyme arthritis with oral doxycycline for 28 days. A partial response can justify a second oral course, whereas minimal or absent response supports intravenous ceftriaxone for 2-4 weeks. After an oral course and an intravenous course, persistent inflammatory arthritis is postantibiotic Lyme arthritis; refer to rheumatology for consideration of intra-articular corticosteroid injection, disease-modifying antirheumatic therapy, or other advanced anti-inflammatory treatment rather than serial antibiotic courses. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf
Counsel patients beginning antibiotics about Jarisch-Herxheimer reaction: transient fever, chills, myalgias, headache, and worsening of skin lesions can begin within 1-12 hours, usually resolves within 24-48 hours, and occurs in approximately 5%-15% of treated patients. Continue antibiotics and use acetaminophen or an oral NSAID for symptom control unless another acute process is suspected. PubMed+1PubMedLyme disease: diagnosis and managementPubMedLyme Disease - StatPearls - NCBI Bookshelf
Erythema migrans: doxycycline 10 days; amoxicillin or cefuroxime axetil 14 days. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf
Lyme carditis managed outpatient: doxycycline, amoxicillin, or cefuroxime; total duration 14-21 days. BMJBMJLyme disease - Management Approach | BMJ Best Practice
Lyme arthritis: doxycycline 28 days initially; intravenous ceftriaxone for 2-4 weeks if response to oral therapy is minimal or absent. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf
Persistent synovitis after oral and intravenous therapy: switch the management frame from active infection to postantibiotic inflammatory arthritis and involve rheumatology. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf
| Manifestation | Initial regimen | Duration | Reassessment trigger |
|---|---|---|---|
| Erythema migrans without neurologic or cardiac involvement | Doxycycline; alternatives amoxicillin or cefuroxime axetil. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | Doxycycline 10 days; amoxicillin or cefuroxime 14 days. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | New neurologic, cardiac, or objective articular findings require syndrome-specific reassessment. |
| Lyme carditis not requiring hospitalization | Oral doxycycline, amoxicillin, or cefuroxime. BMJBMJLyme disease - Management Approach | BMJ Best Practice | 14-21 days. BMJBMJLyme disease - Management Approach | BMJ Best Practice | Syncope, dyspnea, chest pain, palpitations, or conduction disease warrants monitored evaluation. PubMedPubMedLyme disease: diagnosis and management |
| Lyme arthritis | Oral doxycycline. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | 28 days. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | Partial response may support a second oral course; minimal or no response supports intravenous ceftriaxone for 2-4 weeks. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf |
| Postantibiotic Lyme arthritis | Rheumatologic anti-inflammatory strategy, including possible intra-articular corticosteroid or DMARD-based treatment. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | Individualized. | Avoid repeated antibiotic cycles after oral and intravenous treatment have failed to resolve synovitis. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf |
Persistent symptoms after treatment
Do not use persistence of fatigue, pain, or cognitive complaints alone as evidence of treatment failure. After early Lyme disease treatment, systemic complaints may persist at 3 months in approximately one in four patients, although most improve over time; reassess for objective recurrent or new Lyme manifestations and for non-Lyme explanations before considering further antimicrobial therapy. PubMedPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Available controlled trials of prolonged antibiotic treatment in patients with persistent symptoms and a history of Lyme disease have been cited in neurologic reviews, while standard management sources describe typical treatment courses of 2-4 weeks and note no convincing evidence supporting prolonged treatment. The Lancet+1The LancetLyme borreliosisNatureAn ultra-high-density protein microarray for high throughput ...
Prevention
Restrict post-exposure prophylaxis to high-risk Ixodes bites
Prophylaxis is not routine after every tick bite.
Offer antibiotic prophylaxis only when all high-risk criteria are satisfied: the removed tick is identified as adult or nymphal Ixodes scapularis, estimated attachment exceeds 36 hours, local tick infection prevalence with Borrelia burgdorferi exceeds 20%, doxycycline can be started within 72 hours of removal, and doxycycline is not contraindicated. The recommended regimen is a single dose of doxycycline. PubMedPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Do not substitute another antibiotic for prophylaxis when doxycycline cannot be used, including pregnancy, lactation, or children younger than 8 years in the guideline criteria. Instead, provide symptom surveillance and instruct the patient to seek evaluation for erythema migrans, fever, facial palsy, new monoarthritis, or cardiopulmonary symptoms. PubMedPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
A negative history of a recognized tick bite should not exclude Lyme disease when an epidemiologically compatible syndrome is present; patient-recognized attachment is an imperfect exposure marker. Conversely, treating all nonspecific symptoms after a bite drives false-positive testing and unnecessary antibiotics because test specificity matters most in low-pretest-probability populations. PubMedPubMedLaboratory Diagnosis of Lyme Disease - Advances and Challenges
Prophylaxis timing: begin single-dose doxycycline within 72 hours of tick removal. PubMedPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Ecologic threshold: local tick infection rate greater than 20%. PubMedPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
If high-risk criteria are not met: observe for compatible illness rather than prescribing an alternative prophylactic regimen. PubMedPubMedCommissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf
Follow-up
Monitor clinical endpoints, not antibody clearance
Persistent seropositivity is expected and should not determine cure or retreatment.
Follow erythema migrans by lesion evolution and systemic symptom trajectory, carditis by symptoms and ECG findings, and arthritis by joint examination and function. Do not order serial serology to document response because antibodies can persist for years and available assays cannot distinguish active from inactive infection. PubMedPubMedLaboratory Diagnosis of Lyme Disease - Advances and Challenges
If fever is prominent with thrombocytopenia or other laboratory abnormalities after Ixodes exposure, evaluate for tick-borne coinfection rather than attributing all findings to Lyme disease. A reported tick-borne case with fever and thrombocytopenia illustrates potential diagnostic overlap with ehrlichial illness, and Ixodes ticks may harbor Borrelia miyamotoi in addition to Lyme spirochetes. The Lancet+1The LancetSupplementary appendix 1CDCPDF - 8.24 MB - 183 pages
For persistent or recurrent symptoms, re-anchor the diagnosis to objective evidence: a new erythema migrans lesion, a documented conduction abnormality, a compatible neurologic syndrome, or persistent inflammatory synovitis. In the absence of objective evidence, broaden the differential rather than using an isolated positive serologic result as proof of ongoing infection. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesIDSALyme Disease
Do not use antibody titers to assess microbiologic cure. PubMedPubMedLaboratory Diagnosis of Lyme Disease - Advances and Challenges
Repeat ECG-based assessment when carditis symptoms recur or persist. PubMedPubMedLyme disease: diagnosis and management
Reevaluate fever with thrombocytopenia for non-Lyme tick-borne infection or coinfection. The Lancet+1The LancetSupplementary appendix 1CDCPDF - 8.24 MB - 183 pages
Escalate persistent arthritis after oral and intravenous treatment to rheumatology-directed anti-inflammatory management. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf
| Error | Why it misleads | Corrective action |
|---|---|---|
| Testing a classic erythema migrans lesion before treating | Early serology has limited sensitivity and testing is unnecessary for a classic lesion. PubMed+1PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedLyme Disease - StatPearls - NCBI Bookshelf | Treat clinically with the recommended short oral regimen. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf |
| Calling a first-tier EIA alone positive | Two-tier testing requires concordant second-tier testing. CDCCDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC | Complete the two-step algorithm before interpreting serostatus. CDCCDCClinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC |
| Using isolated late IgM as evidence of active Lyme disease | IgM has limited relevance after the first month and can be falsely interpreted. PubMed+2PubMedLaboratory Diagnosis of Lyme Disease - Advances and ChallengesPubMedImmunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive ApproachesCDCLyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDC | Assess IgG pattern, clinical syndrome, and alternate diagnoses. |
| Using repeat antibodies to explain ongoing symptoms | Seropositivity can persist for years and does not establish active infection. PubMedPubMedLaboratory Diagnosis of Lyme Disease - Advances and Challenges | Base retreatment decisions on new objective manifestations. |
| Repeating antibiotics for refractory synovitis after oral and intravenous therapy | Persistent disease may be postantibiotic inflammatory arthritis. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf | Refer for rheumatologic management, including consideration of intra-articular corticosteroid or DMARD therapy. PubMedPubMedLyme Disease - StatPearls - NCBI Bookshelf |
References
- Clinical characteristics and serological profiles of Lyme ... — www.thelancet.com · www.thelancet.com
- Systematic comparisons between Lyme disease and post ... — www.thelancet.com · www.thelancet.com
- Lyme borreliosis — www.thelancet.com · www.thelancet.com
- Lyme disease - Management Approach | BMJ Best Practice — bestpractice.bmj.com · bestpractice.bmj.com
- Supplementary appendix 1 — www.thelancet.com · www.thelancet.com
- Rapid single-tier serodiagnosis of Lyme disease | Nature Communications — www.nature.com · www.nature.com
- Lyme Disease Patient Trajectories Learned from Electronic Medical Data for Stratification of Disease Risk and Therapeutic Response | Scientific Reports — www.nature.com · www.nature.com
- Pilot study of psilocybin in patients with post-treatment lyme disease | Scientific Reports — www.nature.com · www.nature.com
- An ultra-high-density protein microarray for high throughput ... — www.nature.com · www.nature.com
- Infectious Neuropathies — journals.lww.com · journals.lww.com
- Lyme disease : Current Opinion in Rheumatology — journals.lww.com · journals.lww.com
- Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Laboratory Diagnosis of Lyme Borreliosis - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Clinical Testing and Diagnosis for Lyme Disease | Lyme Disease | CDC — www.cdc.gov · www.cdc.gov
- Laboratory Diagnosis of Lyme Disease - Advances and Challenges — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Lyme Disease — www.idsociety.org · www.idsociety.org
- Lyme Disease (Borrelia burgdorferi) 2022 Case Definition | CDC — ndc.services.cdc.gov · ndc.services.cdc.gov
- PDF - 8.24 MB - 183 pages — wwwnc.cdc.gov · wwwnc.cdc.gov
- Lyme disease: diagnosis and management - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Lyme disease: diagnosis and management — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Lyme Disease - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Commissioned Papers - Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- IDSA 2020 Guideline on Diagnosis and Management of Babesiosis — www.idsociety.org · www.idsociety.org